The Effectiveness of Ferrous Bisglycinate in the Control of Iron Deficiency in Pregnant Women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171207001

Enrollment

120

Registered

2017-12-07

Start date

2018-01-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency in pregnant women Iron status&#44

Interventions

Ferrous bisglycinate is the iron binding with glycine,Ferrous fumarate is the iron salt of fumaric acid.

Experimental Dietary Supplement,Active Comparator Dietary Supplement

Ferrous bisglycinate ,Ferrous fumarate

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Women > 18 years of age, with a normal singleton pregnancy 2) First visit at the hospital will be at 12-16 weeks of gestation 3) Serum ferritin < 30 Âµg/L

Exclusion criteria

Exclusion criteria: 1) Has gestational diabetes mellitus, pre-eclampsia, and severe anaemia 2) Has haemoglobinopathies 3) Has iron deficiency before pregnancy 4) Has chronic diarrhea, gastrointestinal disorders and/or iron malabsorption 5) Treatment with aspirin 6) Take any other iron or mineral supplements 7) Smoking

Design outcomes

Primary

Measure	Time frame
Iron status 6 months Blood parameters	—

Secondary

Measure	Time frame
Oral/Gastrointestinal side effects 6 months Questionnaire,Quality of life/ general well-being 6 months Questionnaire	—

Countries

Thailand

Contacts

Public ContactAkkarach Bumrungpert

Mahidol University

abnutrition@yahoo.com66877099957

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026